Taku Miyoshi

1.2k total citations
26 papers, 949 citations indexed

About

Taku Miyoshi is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Taku Miyoshi has authored 26 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Nephrology. Recurrent topics in Taku Miyoshi's work include Ion Transport and Channel Regulation (13 papers), Hormonal Regulation and Hypertension (12 papers) and Electrolyte and hormonal disorders (6 papers). Taku Miyoshi is often cited by papers focused on Ion Transport and Channel Regulation (13 papers), Hormonal Regulation and Hypertension (12 papers) and Electrolyte and hormonal disorders (6 papers). Taku Miyoshi collaborates with scholars based in Japan and United States. Taku Miyoshi's co-authors include Masataka Adachi, Kenichiro Kitamura, Kimio Tomita, Naoki Shiraishi, Hiroshi Nonoguchi, Takefumi Narikiyo, Kozo Iwashita, Yutaka Kakizoe, Naoki Wakida and Julie Chao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Taku Miyoshi

24 papers receiving 939 citations

Peers

Countries citing papers authored by Taku Miyoshi

Since Specialization

Citations

This map shows the geographic impact of Taku Miyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taku Miyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taku Miyoshi more than expected).

Fields of papers citing papers by Taku Miyoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taku Miyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taku Miyoshi. The network helps show where Taku Miyoshi may publish in the future.

Co-authorship network of co-authors of Taku Miyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Taku Miyoshi. A scholar is included among the top collaborators of Taku Miyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taku Miyoshi. Taku Miyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A serine protease inhibitor camostat mesilate prevents podocyte apoptosis and attenuates podocyte injury in metabolic syndrome model rats 2021 ·Journal of Pharmacological Sciences ·Teruhiko Mizumoto, Yutaka Kakizoe, (unknown), (unknown), (unknown), Kohei Uchimura, Masataka Adachi, (unknown), (unknown), Jun Morinaga, Taku Miyoshi, Yuichiro Izumi, Takashige Kuwabara, Yoshiki Sakai, Kimio Tomita, Kenichiro Kitamura, Masashi Mukoyama	5
2	Autosomal dominant Alport syndrome due to a COL4A4 mutation with an additional ESPN variant detected by whole-exome analysis 2019 ·CEN Case Reports ·Yuichiro Izumi, (unknown), (unknown), (unknown), Miyuki Nakagawa, Ken Saida, Noriko Miyake, (unknown), Yutaka Kakizoe, Taku Miyoshi, Yukimasa Kohda, Yohei Misumi, Naomichi Matsumoto, Yukio Ando, Masashi Mukoyama	0
3	Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model 2016 ·Journal of Pharmacological Sciences ·Yuki Narita, Miki Ueda, Kohei Uchimura, Yutaka Kakizoe, (unknown), Teruhiko Mizumoto, Jun Morinaga, (unknown), (unknown), Masataka Adachi, Taku Miyoshi, Yoshiki Sakai, Daisuke Kadowaki, Sumío Hirata, Masashi Mukoyama, Kenichiro Kitamura	12
4	A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity 2016 ·Journal of Pharmacological Sciences ·Yutaka Kakizoe, (unknown), (unknown), (unknown), (unknown), Kohei Uchimura, Jun Morinaga, Teruhiko Mizumoto, Masataka Adachi, Taku Miyoshi, Yoshiki Sakai, Kimio Tomita, Masashi Mukoyama, Kenichiro Kitamura	8
5	The Serine Protease Inhibitor Camostat Mesilate Attenuates the Progression of Chronic Kidney Disease through its Antioxidant Effects 2015 ·The Nephron journals/Nephron journals ·Miki Ueda, Kohei Uchimura, Yuki Narita, (unknown), Teruhiko Mizumoto, Jun Morinaga, (unknown), Yutaka Kakizoe, Masataka Adachi, Taku Miyoshi, Naoki Shiraishi, Daisuke Kadowaki, Yoshiki Sakai, Masashi Mukoyama, Kenichiro Kitamura	13
6	The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling 2014 ·Nature Communications ·Kohei Uchimura, (unknown), Teruhiko Mizumoto, (unknown), Yutaka Kakizoe, Jun Morinaga, (unknown), (unknown), Miki Ueda, Masataka Adachi, Taku Miyoshi, Naoki Shiraishi, Wataru Ogawa, (unknown), Tatsuya Kondo, Takeshi Matsumura, Eiichi Araki, Kimio Tomita, Kenichiro Kitamura	46
7	The antifibrotic effect of a serine protease inhibitor in the kidney 2013 ·American Journal of Physiology-Renal Physiology ·Jun Morinaga, Yutaka Kakizoe, Taku Miyoshi, (unknown), Miki Ueda, Teruhiko Mizumoto, (unknown), Kohei Uchimura, (unknown), Naoki Shiraishi, Masataka Adachi, Yoshiki Sakai, Kimio Tomita, Kenichiro Kitamura	16
8	Aberrant ENaC activation in Dahl salt-sensitive rats 2009 ·Journal of Hypertension ·Yutaka Kakizoe, Kenichiro Kitamura, (unknown), Naoki Wakida, (unknown), Taku Miyoshi, Naoki Shiraishi, Masataka Adachi, Zheng Zhang, Shyama Masilamani, Kimio Tomita	68
9	Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension 2008 ·Journal of Hypertension ·(unknown), Yutaka Kakizoe, Taku Miyoshi, Naoki Wakida, (unknown), Naoki Shiraishi, Masataka Adachi, Kimio Tomita, Kenichiro Kitamura	56
10	Successful Treatment of a Patient With Severe Calcific Uremic Arteriolopathy (Calciphylaxis) by Etidronate Disodium 2006 ·American Journal of Kidney Diseases ·Naoki Shiraishi, Kenichiro Kitamura, Taku Miyoshi, Masataka Adachi, Yukimasa Kohda, Hiroshi Nonoguchi, (unknown), Yoshihiro Maekawa, Toshihiko Murayama, Masao Tomita, Kimio Tomita	70
11	Liddle’s Syndrome Caused by a Novel Mutation in the Proline-Rich PY Motif of the Epithelial Sodium Channel β-Subunit 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Masato Furuhashi, Kenichiro Kitamura, Masataka Adachi, Taku Miyoshi, Naoki Wakida, Nobuyuki Ura, (unknown), Yasuyuki Shinshi, (unknown), Manabu Hayashi, (unknown), (unknown), Kimio Tomita, Kazuaki Shimamoto	47
12	Effect of Telmisartan on Ambulatory Blood Pressure Monitoring, Plasma Brain Natriuretic Peptide, and Oxidative Status of Serum Albumin in Hemodialysis Patients 2005 ·Hypertension Research ·(unknown), Kenichiro Kitamura, (unknown), Taku Miyoshi, Masataka Adachi, (unknown), (unknown), Hiroshi Nonoguchi, Motoko Tanaka, Kimio Tomita	17
13	Mutations in Human Urate Transporter 1 Gene in Presecretory Reabsorption Defect Type of Familial Renal Hypouricemia 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Naoki Wakida, (unknown), Masataka Adachi, Taku Miyoshi, Hiroshi Nonoguchi, Toshiaki Oka, Osamu Ueda, (unknown), Satoshi Kurihara, (unknown), Hajime Shimada, Oda T, Yuichi Kikuchi, Hirotaka Matsuo, Makoto Hosoyamada, Hitoshi Endou, Masaki Otagiri, Kimio Tomita, Kenichiro Kitamura	46
14	Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients 2004 ·Kidney International ·Makoto Anraku, Kenichiro Kitamura, (unknown), Masataka Adachi, (unknown), Toru Maruyama, Kei Miyanaka, Taku Miyoshi, Naoki Shiraishi, Hiroshi Nonoguchi, Masaki Otagiri, Kimio Tomita	87
15	Inhibition of prostasin expression by TGF-β1 in renal epithelial cells 2004 ·Kidney International ·(unknown), Kenichiro Kitamura, Masataka Adachi, Taku Miyoshi, Naoki Wakida, Junko Nagano, Hiroshi Nonoguchi, Kimio Tomita	18
16	Increased endothelin-1 expression in the kidney in hypercalcemic rats 2003 ·Kidney International ·Naoki Shiraishi, Kenichiro Kitamura, Yukimasa Kohda, Takefumi Narikiyo, Masataka Adachi, Taku Miyoshi, Kozo Iwashita, Hiroshi Nonoguchi, R. Tyler Miller, Kimio Tomita	11
17	Inhibition of Prostasin Secretion by Serine Protease Inhibitors in the Kidney 2003 ·Journal of the American Society of Nephrology ·Kozo Iwashita, Kenichiro Kitamura, Takefumi Narikiyo, Masataka Adachi, Naoki Shiraishi, Taku Miyoshi, Junko Nagano, (unknown), Hiroshi Nonoguchi, Kimio Tomita	30
18	Regulation of prostasin by aldosterone in the kidney 2002 ·Journal of Clinical Investigation ·Takefumi Narikiyo, Kenichiro Kitamura, Masataka Adachi, Taku Miyoshi, Kozo Iwashita, Naoki Shiraishi, Hiroshi Nonoguchi, Li-Mei Chen, Karl X. Chai, Julie Chao, Kimio Tomita	102
19	Activation of Epithelial Sodium Channels by Prostasin in Xenopus Oocytes 2001 ·Journal of the American Society of Nephrology ·Masataka Adachi, Kenichiro Kitamura, Taku Miyoshi, Takefumi Narikiyo, Kozo Iwashita, Naoki Shiraishi, Hiroshi Nonoguchi, Kimio Tomita	98
20	A Calcium-activated Cation Current by an Alternatively Spliced Form of Trp3 in the Heart 2000 ·Journal of Biological Chemistry ·(unknown), Taku Miyoshi, Mitsunobu Murata, Kenichi Ishibashi, Masashi Imai, Makoto Suzuki	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact